Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaobin Li

Showing results (331-340 of 340) with videos related to

Pageof 34
Sort By:
You have reached the last page of results.This site can display upto 340 results.
Communications Biology|February 13, 2026
Surface decoration of bacteria generates robust living therapeutics for improved ulcerative colitis therapyJunyu Liu, Zhihao Fang, Xiaobin Li, et al.
Advanced Healthcare Materials|February 12, 2026
De Novo Development of Bioresponsive Nanoparticles With Antimicrobial Activity to Treat Bacterial InfectionsLiang Zhao, Junyu Liu, Xiaobin Li, et al.
CPT: Pharmacometrics & Systems Pharmacology|March 16, 2023
Population pharmacokinetics and exposure-response analysis of a single dose of sotrovimab in the early treatment of patients with mild to moderate COVID-19Jennifer E Sager, Asma El-Zailik, Julie Passarell, et al.
Leukemia & Lymphoma|September 25, 2019
Exposure-response analysis of venetoclax in combination with rituximab in patients with relapsed or refractory chronic lymphocytic leukemia: pooled results from a phase 1b study and the phase 3 MURANO studyRong Deng, Leonid Gibiansky, Tong Lu, et al.
Journal of Medical Genetics|March 26, 2021
Genetic origin of sporadic cases and RNA toxicity in neuronal intranuclear inclusion diseaseJianwen Deng, Binbin Zhou, Jiaxi Yu, et al.
Clinical Pharmacokinetics|June 19, 2019
Bayesian Population Model of the Pharmacokinetics of Venetoclax in Combination with Rituximab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia: Results from the Phase III MURANO StudyRong Deng, Leonid Gibiansky, Tong Lu, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|April 5, 2014
[A prospective multicenter clinical trial of extralevator abdominoperineal excision for locally advanced low rectal cancer]Zhenjun Wang, Qun Qian, Yong Dai, et al.
Journal of Global Antimicrobial Resistance|March 4, 2023
Whole genome sequencing of multidrug-resistant Proteus mirabilis strain PM1162 recovered from a urinary tract infection in ChinaJing Yang, Ge Shan, Guangchao Yu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 1, 2021
Mutational Profile Evaluates Response and Survival to First-Line Chemotherapy in Lung CancerYayi He, Lele Song, Hao Wang, et al.
Nature Communications|February 28, 2023
Unintended consequences of combating desertification in ChinaXunming Wang, Quansheng Ge, Xin Geng, et al.
Pageof 34

Showing results (331-340 of 340) with videos related to

Sort By:
Pageof 34
You have reached the last page of results.This site can display upto 340 results.
Communications Biology|February 13, 2026
Surface decoration of bacteria generates robust living therapeutics for improved ulcerative colitis therapyJunyu Liu, Zhihao Fang, Xiaobin Li, et al.
Advanced Healthcare Materials|February 12, 2026
De Novo Development of Bioresponsive Nanoparticles With Antimicrobial Activity to Treat Bacterial InfectionsLiang Zhao, Junyu Liu, Xiaobin Li, et al.
CPT: Pharmacometrics & Systems Pharmacology|March 16, 2023
Population pharmacokinetics and exposure-response analysis of a single dose of sotrovimab in the early treatment of patients with mild to moderate COVID-19Jennifer E Sager, Asma El-Zailik, Julie Passarell, et al.
Leukemia & Lymphoma|September 25, 2019
Exposure-response analysis of venetoclax in combination with rituximab in patients with relapsed or refractory chronic lymphocytic leukemia: pooled results from a phase 1b study and the phase 3 MURANO studyRong Deng, Leonid Gibiansky, Tong Lu, et al.
Journal of Medical Genetics|March 26, 2021
Genetic origin of sporadic cases and RNA toxicity in neuronal intranuclear inclusion diseaseJianwen Deng, Binbin Zhou, Jiaxi Yu, et al.
Clinical Pharmacokinetics|June 19, 2019
Bayesian Population Model of the Pharmacokinetics of Venetoclax in Combination with Rituximab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia: Results from the Phase III MURANO StudyRong Deng, Leonid Gibiansky, Tong Lu, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|April 5, 2014
[A prospective multicenter clinical trial of extralevator abdominoperineal excision for locally advanced low rectal cancer]Zhenjun Wang, Qun Qian, Yong Dai, et al.
Journal of Global Antimicrobial Resistance|March 4, 2023
Whole genome sequencing of multidrug-resistant Proteus mirabilis strain PM1162 recovered from a urinary tract infection in ChinaJing Yang, Ge Shan, Guangchao Yu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 1, 2021
Mutational Profile Evaluates Response and Survival to First-Line Chemotherapy in Lung CancerYayi He, Lele Song, Hao Wang, et al.
Nature Communications|February 28, 2023
Unintended consequences of combating desertification in ChinaXunming Wang, Quansheng Ge, Xin Geng, et al.
Pageof 34